Accreditation Statements

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses

The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Credit Designations

Physicians

eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6 contact hours for the six newsletters in this program.

Podcast: This 0.5 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing.
To obtain contact hours, you must complete this Education Activity and post-test before November 16, 2018.

Respiratory Therapists For United States: Visit this page to confirm that your state will accept the CE Credits gained through this program. For Canada: Visit this page to confirm that your province will accept the CE Credits gained through this program.

Intended Audience

This activity has been developed for pulmonologists, pediatric pulmonologists, gastroenterologists, pediatricians, infectious disease specialists, respiratory therapists, dieticians, nutritionists, nurses, and physical therapists.

There are no fees or prerequisites for this activity.

eNewsletter: The estimated time to complete this activity is one hour

Podcast: The estimated time to complete this activity is 30 minutes.

Course Format

The eCysticFibrosis Review series will consist of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with cystic fibrosis. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of pulmonary specialists. The activities are delivered as 6 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 6 newsletters and 6 podcasts in order to earn CME credit.

Date of release: December 30, 2015
Expiration date: December 29, 2017

Planners Disclosures

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

Dr. Noah Lechtzin has reported that he has served as principal investigator for Vertex Pharmaceuticals Incorporated. In addition, he has served as a consultant for Hill Rom.

Suzanne Sullivan has received honorarium from Vertex Pharmaceuticals Incorporated.

No other planners have indicated that they have any financial interest or relationships with a commercial entity.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Statement of Need

Based on a review of the current literature, including national and regional measures, detailed conversations with expert educators at Johns Hopkins, and a survey of potential program participants, this program will address the following core patient care gaps:

Disease-Modifying Therapies

• Although ivacaftor is approved for treating patients with specific CFTR mutations (eg, G551D, R117H), clinicians remain uncertain about its use in young children, the risk for possible drug interactions, and recent data describing its use in other mutations.
• Clinicians may be unfamiliar with emerging data describing novel and in-development agents, including correctors and potentiators, to manage patients with CFTR class II mutations, such as F508del.
• Clinicians may be unaware of recent studies of novel agents, including correctors and potentiators, targeting class I CFTR mutations and the potential role of these agents in clinical care.

Nutrition

• Clinicians who manage patients with chronic HCV infection may be unclear about how new/emerging drugs target different points in the viral life cycle.
• Clinicians may be unaware of emerging clinical trial data for current and emerging HCV therapies.

Pseudomonas aeruginosa

• Clinicians lack information to most appropriately determine the optimal choice of inhaled antibiotics to manage chronic Pa infection.
• Clinician scheduling of inhaled antibiotic maintenance therapy lacks adequate evidence-based guidance.
• The most effective use of inhaled antibiotics for the treatment of pulmonary exacerbations remains unknown.
• The evidence-basis describing inhaled antibiotic protocols for Pa early eradication remains confusing.

This activity is supported by educational grants from Gilead Sciences, Inc, Vertex Pharmaceuticals Incorporated, and Chiesi USA, Inc.

Successful Completion

To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.

A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit.

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.

Confidentiality Disclaimer for CME Activity Participants

I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, HIPAA@jhmi.edu

"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME Questions, please contact the CME Office (410) 955-2959 or e-mail cmenet@jhmi.edu. For CME Certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education Turner 20/720 Rutland Avenue Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Internet CME/CE Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.

Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.edu.

Hardware & Software Requirements

• A computer with an internet connection
• An HTML5 compliant web browser or Internet Explorer 8 (and higher)

Copyright © JHUSOM and eCysticFibrosis Review | Presented by JHUSOM in collaboration with DKBmed.